Skip to content
2000
Volume 23, Issue 14
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

The present application reports a series of novel Arcyriaflavin-A derivatives as PIM kinase inhibitors for the effective treatment of cancer. The application also describes the synthesis of compounds in detail, use, pharmaceutical composition, pharmaceutically acceptable salts, and treatment.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520623666230508101745
2023-08-01
2025-09-05
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520623666230508101745
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test